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PAPUA, INDONESIA
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Abstract. Immune responses directed at glycosylphosphatidylinositol (GPI) anchors of Plasmodium falciparum may
offer protection against symptomatic malaria. To independently explore the effect of age on generation of the anti-GPI
IgG response, we measured serum anti-GPI IgGs in a longitudinal cohort of migrant Javanese children (6–12 years old)
and adults (20 years old) with equivalent numbers of exposures to P. falciparum in Papua, Indonesia. While the peak
response in adults was achieved after a single infection, comparable responses in children required 3–4 infections.
Significantly fewer children (16%) than adults (41%) showed a high (optical density > 0.44) anti-GPI IgG response (odds
ratio [OR] 3.8, 95% confidence interval [CI] 2.3–6.3, P < 0.0001), and adults were more likely to show a persistently
high response (OR 5.5, 95% CI 1.0–56.8, P 0.03). However, the minority of children showing a strong response
were significantly less likely to experience symptoms with subsequent parasitemia compared with those with a weak
response (OR  4.0, 95% CI  1.1–13.8, P  0.02). This effect was not seen among high- and low-responding adults
(OR  1.2, 95% CI  0.5–2.8, P 0.60). Host age, independent of cumulative exposure, apparently represents a key
determinant of the quantitative and qualitative nature of the IgG response to P. falciparum GPI.
INTRODUCTION
Malaria caused by Plasmodium falciparum infection results
in death for at least one million people annually.1 The inabil-
ity to diminish the global burden of malaria despite the tech-
nological leaps of the past 30 years reflects the broad diffi-
culty of attacking a highly complex parasite impacting the
human host across a diverse array of biologic, geographic,
social, and economic factors.2 Development of a practical vac-
cine remains a critical technological task in the struggle to
contain and diminish morbidity and mortality caused by ma-
laria.3 In sub-Saharan Africa, that task focuses on a vaccine
that induces a non-sterilizing protection from severe disease
among susceptible infants and young children. Adults in this
region have naturally acquired protection against clinical dis-
ease caused by P. falciparum.
Although there is compelling clinical evidence linking class
G immunoglobulins (IgG) with protection against erythro-
cytic malaria in humans,4–9 the precise mechanisms underpin-
ning this correlation remain undefined. Immunoglobulins that
bind to proteins expressed at the merozoite surface are
thought to prevent normal interactions between parasites and
erythrocytes and to initiate parasite destruction,10 thereby re-
ducing the overall parasite burden. Antibodies may also pre-
vent symptomatic malaria through preventing the induction
of pathologic host inflammation by parasite-derived toxins.
Glycosylphosphatidylinositol (GPI) anchors, which represent
the major carbohydrate modification in intraerythrocytic P.
falciparum parasites,11 are released into the host blood
stream upon rupture of erythrocytic schizonts and in mouse
models demonstrate several key properties of a toxin. These
include the induction of tumor necrosis factor-,12 interleu-
kin-1,12 and nitric oxide13 production in macrophages, up-
regulated adhesion molecule expression in endothelial cells,14
and aberrant temperature and glycemic regulation in vivo.12
Several of these properties have been blocked with specific
antibodies.12–15 Furthermore, IgGs induced in mice by vacci-
nation with carrier-conjugated chemically synthesized GPI
are associated with protection against malaria acidosis, pul-
monary edema, cerebral syndrome, and fatality with severe P.
berghei malaria.16
Three recent studies have addressed the issue of whether
anti-GPI immunoglobulins may contribute to anti-toxic im-
munity in human malaria. The use of highly purified P. falci-
parum-derived GPIs as the target antigen in an enzyme-
linked immunosorbent assay (ELISA) format resulted in the
detection of specific IgM17,18 and IgG17–19 in the plasma and
sera of adults and children exposed to endemic or seasonal P.
falciparum malaria. While the anti-GPI IgG response was
found to correlate with protection against malarial anemia
and fever in Kenyan children,17 no significant relationship
between levels of antibodies to GPI and protection against
malaria symptoms was found in Kenyan adults17 or Gambian
children.19 However, a consistent finding among these reports
was that both the prevalence and concentration of anti-GPI
IgG increases in an age-dependent manner. Positive re-
sponses were least frequent in those 5 years old, increased
significantly during older childhood (5–9 years old) and early
adolescence (10–14 years old), and peaked in the late teenage
(15–19) and adult (20) years.17–19 A similar pattern was
observed for GPI-specific IgM responses, although generally
these antibodies were much less common than IgGs.18 While
the possibility has been raised that such age-dependent dif-
ferences in immunity may be ontogenetic in nature,19 it is
difficult to directly address this issue by studies of infants,
children, and adults having experienced lifelong, heavy expo-
sure to infection. Age correlates directly with cumulative ex-
posure to GPI and other P. falciparum antigens in such popu-
lations.
We examined the effect of age on the generation of GPI-
specific humoral immunity. We had access to a longitudinal
cohort of Javanese children and adults exposed to multiple P.
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falciparum infections following migration to endemic Indone-
sian Papua. This study provided unique analytical insight by
allowing separation of the effects of age from those of cumu-
lative exposure. The number of infections in this cohort was
carefully documented and we compared anti-GPI IgG re-
sponses between adults and children having equal exposure to
infection.
MATERIALS AND METHODS
Study site and subjects.A longitudinal study of 243 Ja-
vanese migrants (97 children 6–12 years, and 146 adults aged
 20 years) to SP2 village in Armopa (139° 32E, 2° 16S),
northeastern Papua, Indonesia (where transmission of P. fal-
ciparummalaria is perennial) commenced in September 1996,
and terminated after 33 months with 168 subjects remaining
under routine follow-up. All subjects were enrolled and under
observation within 36 hours of arriving in Papua. During the
period that virtually all adults in this cohort were born and
raised on the island of Java, the available surveillance data
suggests the risk of one prior episode of malaria to be less
than 0.005%.20 Thus, after careful screening by history of
prior residence and the application of other strict inclusion
criteria, we considered the subjects to be essentially malaria-
naïve at enrollment.
Findings presented here represent work performed in ac-
cordance with code 32 of Federal Regulation Part 219 (Pro-
tection of Human Subjects), U.S. Navy (SECNAVINST
3900.39B) and Ministry of Health, Republic of Indonesia
regulations governing the use of human subjects for medical
research. The work was reviewed and approved by U.S. Navy
and Indonesian committees for protection of human subjects
of medical research. Informed consent was obtained from all
adult participants and from parents or legal guardians of mi-
nors.
Detection and classification of P. falciparum infection.All
episodes of symptomatic and asymptomatic parasitemia were
detected through rigorous and systematic follow-up. This in-
cluded every two weeks (routine) and symptom-associated
(non-routine) blood smear collection, and in-home clinical
assessment three times per week. Children and adults expe-
rienced qualitatively equal incidence densities of P. falci-
parum parasitemia over the 33-month duration of this study,
decreasing from 1.5 infections per person year in the first 12
months to < 1.0 infections per person year in the latter months
(Krisin and others, unpublished data). Positive blood films
collected from subjects registering complaints of illness were
classified as symptomatic infections and prompted immediate
therapy with either chloroquine or mefloquine. This approach
almost certainly explains the very low risk of severe malaria in
the cohort; only eight subjects required intravenous quinine
therapy through the 33 months of follow-up. Parasitemia de-
tected in routine blood films collected from subjects register-
ing no complaint of illness (either by voluntary presentation
or scheduled in-home assessment) were classified as asymp-
tomatic infections. A sequence of infections (which included
both symptomatic and asymptomatic parasitemias) was con-
structed for each subject. Venous blood samples collected
from subjects at intervals of two months served as the source
of convalescent sera for both symptomatic and asymptomatic
infections. Convalescence was defined as the period 14–70
days following patent parasitemia.
Quantification of IgG antibodies to GPI by ELISA. Free P.
falciparum GPI was obtained from mid-schizont stage cul-
tured P. falciparum (FCR-3 strain) parasites using rigorous
protocols as previously described17. Briefly, packed culture-
derived parasites were lyophilized, extracted in chloroform/
methanol followed by chloroform/methanol/water, dried, and
then partitioned between water and water-saturated 1-bu-
tanol. The dry residue obtained from the organic layer was
extracted with 80% aqueous 1-propanol, and GPIs were pu-
rified by high performance and thin layer chromatography;
representative chromatographs have been published previ-
ously.17 For ELISAs, purified, free GPI was dissolved in
methanol, coated (20 ng/mL in 100 L) onto 96-well micro-
titer plates, and used in an ELISA format17 for quantification
of IgG antibodies to GPI in dilute sera (1:100, in duplicate).
The GPI-coated wells containing negative and positive con-
trol sera were also analyzed in parallel, as were buffer-coated
wells containing control and migrant sera. Negative control
sera was collected from P. falciparum-naive Indonesian resi-
dents of Jakarta and P. falciparum-naive, slide-proven P.
vivax-infected Javanese migrants who had been resident in
Papua for 7–19 months and endured two or more prior P.
vivax infections. Positive control sera were collected from
lifelong residents of endemic Papua and Sulawesi, Indonesia.
Buffer-coated wells with negative and positive control serum,
and migrant serum collected from adults and children at en-
rolment, and 3–6, 7–12, and > 12 months following enrollment
were also included. The levels of anti-GPI IgGs are expressed
as the mean measured optical density values ( 405 nm) for
each sample.
Statistical analysis. Non-parametric methods (Kruskal-
Wallace analysis of variance [ANOVA] followed by the
Mann-Whitney rank sum test) were used to determine the
effect of age on anti-GPI OD values at enrollment and the
effect of multiple infections on OD values in adults and chil-
dren, and to compare enrollment OD values with those of
negative controls. The effect of age on anti-GPI OD values at
each infection was examined by general linear model univari-
ate ANOVA, which used matched enrollment values as a
covariate factor. The cut-off for positive and negative values
(0.44 OD units) was determined by calculation of the mean +
2 × SD of log-transformed enrollment data (since raw data
was not normally distributed). The effect of cumulative infec-
tion on anti-GPI OD values in subjects with persistently high
OD values was examined by general linear model repeated
measures ANOVA, which used matched enrollment values as
a covariate factor. Results expressing frequencies were com-
pared by Mantel-Haenzel odds ratio (OR) analysis using
Cornfield 95% confidence intervals (CIs) when expected cell
values were >5, or exact CIs when expected cell values were
5. Analysis was carried out using SPSS version 8.0 (SPSS,
Inc., Chicago, IL) and Epi-Info version 6 (Centers for Disease
Control and Prevention, Atlanta, GA).
RESULTS
Negligible IgG antibody response to GPI in migrants at
enrollment. The OD values were low in most migrants on the
day of their enrollment in the study (median  0.08), al-
though some variability was evident (Figure 1). The enroll-
ment values were not significantly different from those of
negative control serum (P  0.7). Enrollment values were
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higher (P < 0.001; Figure 1) in adults (median  0.11) com-
pared with children (median  0.06).
Anti-GPI response after a single P. falciparum infection.
There was a significant effect of a single infection on levels of
IgG antibody to GPI. Relative to the median OD value at
enrollment in adults, the median value at convalescence 1 in
adults increased by 2.3-fold (P < 0.001; Figure 1A). Although
less pronounced (increase in median value was only 1.7-fold),
the OD values in children were also significantly increased at
convalescence 1 relative to those at enrollment (P  0.03;
Figure 1B).
Longitudinal anti-GPI IgG response to multiple P. falci-
parum infections in adults and children.We examined the
longitudinal effect of 1–9 P. falciparum infections on the IgG
antibody responses to GPI in adults and children separately.
As had been seen at infection 1, anti-GPI OD levels were
significantly higher in adults at each of infections 2, 3, 4, 5, and
6–9 compared with their enrollment values (P 0.001; Figure
1A). However, among adults, OD values were not signifi-
cantly elevated with additional exposure beyond infection 1
(P > 0.4).
In children, IgG antibody levels to GPI were also signifi-
cantly higher at each of infections 2, 3, 4, 5, and 6–9 compared
with their enrollment levels (P 0.03; Figure 1B). Relative to
values at infection 1, there was no significant effect of infec-
tions 2 or 3 on levels of IgG antibody to GPI in children.
However, IgG levels were significantly higher at infection 4
compared with both infection 1 (P  0.005) and infection 2
(P 0.02) in this age group. The IgG levels were not signifi-
cantly different between infections 3 and 4, or infection 4 and
subsequent infections (P  0.1).
To determine the effect of age on the longitudinal anti-GPI
IgG response to P. falciparum infection, we compared OD
values in adults and children at each individual infection, and
used matched enrollment values as a covariate factor. At con-
valescence of infection 1 (P 0.001), infection 2 (P 0.003),
and infection 3 (P  0.03), anti-GPI OD values were signifi-
cantly higher in adults compared with children (Figure 1). In
subsequent infections, there was no significant effect of age
on anti-GPI IgG (0.80  P  0.08).
Effect of age on generation of high anti-GPI IgG re-
sponses. It is clear from Figure 1 that although anti-GPI re-
sponses tended to be higher overall in adults than in children
in infections 1–3, there were some children who appeared
capable of mounting an immune response of similar magni-
tude to responsive adults. We divided subjects into those with
high and low anti-GPI IgG responses based on a cut-off value
of 0.44 OD units (cut-off calculated as described in the Ma-
terials and Methods). Accordingly, 41% (108 of 263) of all
convalescent episodes in adults showed a high anti-GPI IgG
response, with the proportion of positive responders increas-
ing from 40% at infection 1 to >50% in infections 4 and 5
(Table 1). In contrast, only 16% (27 of 173) of all convales-
cent sera in children showed a high anti-GPI IgG response
(Table 1). Thus, across all infections, adults were nearly four
times more likely to have a high anti-GPI IgG response than
were children (OR  3.8, 95% CI  2.3–6.3, P < 0.0001).
This relationship was most clearly evident in early infections,
with only 7–12% of children showing high levels of anti-GPI
IgG at infections 1, 2, and 3 (0.02  P  0.001; Table 1).
Although a lower proportion of children (13–32%) than
adults (52–54%) had a high IgG response in infections 4 and
5, these differences were not statistically significant (P 0.06;
Table 1).
We examined the ability to maintain a persistently high
anti-GPI IgG titer among children and adults. Among the 106
adults, 57 (54%) had a high anti-GPI IgG response at least
once during the course of the study. Seventeen of these 57
subjects had no subsequent episodes of infection and thus
offered no further sera for the ELISA. Of the remaining 40
adult subjects, 22 (55%) had persistently high anti-GPI IgG
responses. Of the 73 children, 23 individuals (32%) had a high
anti-GPI IgG response at least once during the course of the
study. Twelve of those 23 subjects offered no further sera, and
2 of the remaining 11 subjects (18%) showed persistently high
anti-GPI IgG responses. Thus, compared with children, adults
FIGURE 1. Anti-glycosylphosphatidylinositol optical density
(OD) values in adults (A) and children (B) at enrollment (enrol) and
convalescence of infections 1, 2, 3, 4, 5, and 6–9. Values are shown as
medians (horizontal lines) with 25th–75th percentiles (boxes), 10th–
90th percentiles (error bars), and 95% confidence intervals (crosses).
Data were compared by Kruskal-Wallis analysis of variance and the
Mann-Whitney rank sum test. Groups without common lower case
letters on the x-axes are significantly different (P < 0.05). Also shown
are individual control (con) OD values. Positive controls shown in A
are one lifelong resident of endemic Papua, Indonesia (, four indi-
vidual experiments) and two lifelong residents of endemic Sulawesi,
Indonesia ( and ). Negative controls shown in A are one male (,
four separate experiments) and two female ( and ) lifelong resi-
dents of malaria-free Jakarta, Indonesia and three Javanese migrants
resident in Papua, Indonesia () infected with Plasmodium vivax.
Controls shown in B are OD values derived using buffer-coated wells
and serum collected from Javanese migrants after 3–6 (, n  9),
7–12 (, n  9) and > 12 months (, n  9) residence in Papua,
Indonesia.
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were 2.5 times more likely to record at least one positive
anti-GPI IgG response (95% CI  1.3–5.0, P  0.003), and
almost six times more likely to have persistently high anti-
GPI IgG responses (OR 5.5, 95% CI 1.0–56.8, P 0.03)
with 1–9 P. falciparum infections. There was no significant
effect of cumulative infection on anti-GPI OD values among
persistently high subjects (P  0.4).
Anti-GPI response and risk of symptoms in subsequent
infection. There were respectively 194 and 117 convalescent
samples available from adults and children who endured one
or more subsequent P. falciparum infections. By classifying
each of these infections as symptomatic or asymptomatic (as
described in the Materials and Methods), we analyzed the
relationship between occurrence of a high anti-GPI IgG re-
sponse and absence of symptoms in the immediately subse-
quent infection. Among adults, 19% (14 of 72) of high and
16% (20 of 122) of low anti-GPI IgG convalescent values
were immediately followed by an asymptomatic infection.
Thus no correlation appeared for the risk of symptoms with
new infection following prior occurrence of a high anti-GPI
IgG response in adults (OR  1.2, 95% CI  0.5–2.8, P 
0.60). Children with a high anti-GPI IgG response were sig-
nificantly more likely to be asymptomatic in the immediately
subsequent infection (41%, 7 of 17) than children with a low
response (15%, 15 of 100; OR  4.0, 95% CI  1.1–13.8,
P  0.02).
DISCUSSION
The GPI anchors of P. falciparum may play a role in the
pathogenesis of malaria. Here we present the results of a
longitudinal analysis of anti-GPI IgG in convalescent serum
of adults and children following migration from Java to hy-
perendemic northeastern Indonesian Papua. The quantita-
tively equal incidence densities of P. falciparum parasitemia
among children and adults over the 33-month duration of this
study, and the sequencing of episodes of parasitemia among
subjects allowed us to examine the effect of age on the im-
mune response independent of differences in cumulative ex-
posure that normally occur among lifelong residents of en-
demic areas. This analysis demonstrated impaired onset of
anti-GPI IgG, diminished peak levels, and weak persistence
of that response among children compared with adults. More-
over, elevated anti-GPI IgG correlated with diminished risk
of fever among children but not adults. Host age, independent
of the effects of cumulative exposure, affected both the quan-
titative and qualitative nature of the humoral immune re-
sponse to GPI of P. falciparum.
Many studies of childhood malaria focus on children 0–3
years old, since it is this age group that bears the burden of
childhood malaria in endemic Africa.17,20,21 Furthermore, it
has been proposed that children 2–3 years old and exposed
to heavy infective pressure since birth exhibit a unique form
of anti-toxic immunity that results in their relatively high fe-
ver threshold despite high parasite densities.20 This phenom-
enon was not the focus of the work presented here. Instead,
we directed our investigation towards older children (6–12
years old) to determine whether previous descriptions of
maturation-dependent, sub-optimal development of clinical
protection against malaria in this particular age group in
Papua20,22 and Africa23 were reflected in immune parameters.
Our findings with anti-GPI IgG argue in favor of intrinsic
age-dependent factors as determinants of the immune re-
sponse to falciparum malaria.20,22,23 The results are also con-
sistent with those reported from populations having lifelong
heavy exposure to infection.17–19 Such distinctions are usually
ascribed to differences in cumulative exposure to infection,
with an optimal immune response thought to correspond with
superior experience of the antigenic repertoire of the para-
site.24,25 Even if an extrinsic factor like exposure to diverse
antigens drives age-dependent differences in humoral im-
mune responses to some antigens of falciparum malaria, one
may not expect to observe such an outcome with responses to
GPI. GPI molecules have been shown to have remarkable
structural consistency, perhaps even identity, between P. fal-
ciparum isolates from four continents.26
That adults showed slightly higher background levels in our
ELISA is not unique. In confirming the specificity of their
GPI ELISA (which was the same as that used in our assays),
Naik and others found that rural Kenyan adult sera have
background levels of reactivity to common acylated phospho-
glycerols, a phenomenon attributed to the propensity of poly-
clonal antibodies to react with common epitopes.17 Given
that our study subjects had migrated from predominantly ru-
ral areas, it would seem likely that their sera would also con-
tain some cross-reactive antibodies, and perhaps this ex-
plained the occasional high OD values that were noted in
some adults and fewer children on the day of enrollment in
our study. Rather than apply a selection bias and exclude
subjects with high background readings, by including matched
enrollment values as a covariate factor we were able to show
that despite differences in enrollment values, anti-GPI IgG
responses were still significantly higher in adults compared
with children. We also found similar background OD values
in 18 serum samples collected 3–6, 7–12, and >12 months
following enrollment, suggesting that the capacity of serum to
stick non-specifically to the ELISA plates did not change over
the 33 months of the study period.
TABLE 1
Effect of age on occurrence of high anti–glycosylphosphatidylinositol (GPI) IgG responses at convalescence*
Infection 1 Infection 2 Infection 3 Infection 4 Infection 5 Infections 6–9 All
A C A C A C A C A C A C A C
Positive 37 7 24 3 18 4 15 8 7 1 7 4 108 27
Negative 55 52 37 39 32 29 14 17 6 7 11 2 155 146
OR 5.0 8.4 4.1 2.3 8.2 0.3 3.8
CI 1.9–13.5 2.2–46.5 1.1–18.2 0.7–8.1 0.6–419.5 0.02–3.1 2.3–6.3
P 0.001 <0.001 0.02 0.14 0.06 0.2 <0.001
* Positive and negative values are numbers of adult (A) and child (C) subjects with high (optical density [OD] > 0.44) and low (OD 0.44) anti-GPI IgG responses at convalescence of infections
1–9. Odd ratio (OR), Cornfield 95% confidence interval (CI), and P values are for a positive response in adults versus children.
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It has long been recognized that overall titers of IgG anti-
bodies, especially of subclasses IgG2 and IgG4, are lower in
infants and pre-pubescent children compared with adults.27,28
While poor anti-GPI responses in young children have been
suggested to result from an inability of neonates and infants
less than two years old to make substantial IgG responses to
carbohydrate or glycolipid antigens,19 differences in immu-
nity between older children and adults remain relatively un-
explored. Kurtis and others hypothesize that the onset of pu-
berty, indicated by increased circulating levels of hormones
such as dehydroepiandrosterone sulfate, somehow induces in
children the capacity to mount adult-like immune responses
to malaria.23 A similar hypothesis has been proposed to ex-
plain age-dependence in immunity against schistosomiasis.29
However, the exact mechanism explaining age-dependence in
generation of antigen-specific immunity in malaria remains
unknown at this time.
In conclusion, we have demonstrated host age as a deter-
minant that acts independently of cumulative exposure in
generation of anti-GPI IgG responses in Javanese migrants to
Indonesian Papua. If indeed older children cannot mount
protective immune response specific to toxins such as GPI,
this could provide some clue as to why, relative to adults, this
age group is predisposed to increased clinical illness with
chronic P. falciparum infection.30 The relative contributions
of intrinsic factors such as host age and of extrinsic factors
such as antigenic diversity to the onset of clinical immunity to
falciparum malaria constitute a question of core importance
to strategies for developing vaccines intended to diminish
morbidity and mortality among young African children.
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